Amgen saw its revenue and net income rise in the fourth quarter of 2021, as COVID-19 treatments made in collaboration with Eli Lilly and Company helped bolster the Thousand Oaks-based biotech company’s finances, Amgen reported Feb. 7. In the fourth quarter of 2021, Amgen generated revenue of $6.8 billion, a 3% increase from the same…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
